Home > Drug Search >
  • Targets: NEDD8 activating enzyme (NAE)
  •   > 
Drug Filter
Category:
chemistry (17) biology (8)
Status:
Approved (7) Phase Ⅲ (3) Phase Ⅱ (6) Phase Ⅰ (9)
Clinical Stage:
Pending (2) Active (12) Discontinued (4)
Bio-Type:
Blood extraction (3) Recombinant polypeptide (1) Whole antibody (1)
Company:
Ferring Pharmaceuticals (1) Helsinn (1) Janssen (2) Johnson & Johnson (1) Lilly (1) Millennium Pharmaceutical (1) Nippon Shinyaku Pharma (1) Nycomed Pharmaceutical (1) Shire (2) Takeda (1) Max Delbrück Center for Molecular Medicine (1) REGiMMUNE (1) GLyPharma (1) Agenix (1) Glenmark Pharma (1) Inspiration Biopharmaceuticals (1) Octapharma (1) vTv Therapeutics (1) CoMentis (1) Zealand Pharma (1) Global Neurotech (1) Toyota Tsusho (1) Baxalta (3) Emory University (1) FIBREX Medical (1) CSL Behring (1) AstraZeneca (3)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (4) Amyotrophic lateral sclerosis (ALS) (1) Arthritis (1) Chronic myeloid leukemia (CML ) (1) Chronic obstructive pulmonary disease (COPD) (1) Delayed graft function (1) Deep vein thrombosis (DVT) (1) Depression (1) Diabetic neuropathic pain (DNP) (1) Diarrhea (1) Endometriosis (1) Epilepsy/Seizures (1) Pancreatitis (1) Heart failure (1) Afibrinogenaemia (1) Migraine (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Parkinson's disease (PD) (1) Pulmonary embolism (1) Venous thromboembolism (VTE) (1) Pain (1) Systemic inflammatory response syndrome (SIRS) (1) Diabetes (1) Hemophilia A (1) Multiple system atrophy (1) Short bowel syndrom (1) Graft versus host disease (1) Bleeding (2) Burns (1) Gastrointestinal disorders (1) Von Willebrand disease (1) Inflammation (1) Shock (1)
Country:
Aprv. Year:
1995 (1) 2008 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top